Teva's Shares Now Trade Directly on the NYSE — Here's What Else Changed

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ) had a busy week that included a major debt refinancing, a milestone shift in how its shares trade on the NYSE and analyst activity. Teva stock is trading near recent highs. Where is TEVA stock headed? Multi-Tranche Senior Notes Offering to Redeem Existing Debt On Sept. 10, Teva announced it successfully priced approximately $4.9 billion (equivalent) of senior notes across five tranches denominated in euros and U.S. dollars, with maturities ranging from 2032 to 2037. The offering, expected to settle on or about September 16, is intended to fund the redemption of several existing note series, including its 6.750% Senior Notes due 2028 and multiple sustainability-linked notes due between 2027 and 2031. The new notes will be unsecured senior obligations of the issuers and unconditionally guaranteed by Teva. The NYSE Direct Listing On September 14, Teva announced its ordinary shares began trading directly on the New York Stock Exchange, completing the company’s planned transition away from its American Depositary Shares program. Shares continue to trade under the ticker “TEVA” on both the NYSE and the Tel Aviv Stock Exchange. “Today mark